Nugene Biopharm Science (Hangzhou) Co., Ltd. is investing 200 million yuan to build a commercial production base and a research and development center, that can meet the urgently needed supply of key raw materials in the mRNA industry chain. The 6000 square meter research and development center has been completed, providing global mRNA customers with NTPs and dNTPs, as well as liposome raw materials, and enzymes involved in in vitro transcription. A commercial production workshop with an annual output of 20 tons of NTPs and 10 tons of dNTPs is under construction.
Date: Sep 1st, 2021